USFDA Approves Sun Pharma's Alopecia Areata Drug - LEQSELVI
July 26, 2024 10:53
Sun Pharma's LEQSELVI (deuruxolitinib) receives USFDA approval for treating severe alopecia areata in adults. This new drug offers hope for patients with this autoimmune disorder causing hair loss.